{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:01:15Z","timestamp":1776762075011,"version":"3.51.2"},"reference-count":31,"publisher":"Jaypee Brothers Medical Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"DOI":"10.5005\/jp-journals-10071-25166","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T11:35:14Z","timestamp":1776598514000},"page":"291-297","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal Tolerance to Maranta arundinacea (Arrowroot) Powder Added to Formula Feeds in Intensive Care Unit Patients: A Nonrandomized Controlled Quasi-experimental Trial"],"prefix":"10.5005","volume":"30","author":[{"given":"Manju","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiny","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Thibault R, Graf S, Clerc A, Delieuvin N, Heidegger CP, Pichard C. Diarrhoea in the ICU: Respective contribution of feeding and antibiotics. Crit Care 2013;17:R153. DOI: 10.1186\/cc12832.","DOI":"10.1186\/cc12832"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Tirlapur N, Puthucheary ZA, Cooper JA, Sanders J, Coen PG, Moonesinghe SR, et al. Diarrhoea in the critically ill is common, associated with poor outcome, and rarely due to iClostridium difficile\/i. Sci Rep 2016;6:24691. DOI: 10.1038\/srep24691.","DOI":"10.1038\/srep24691"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Jack L, Coyer F, Courtney M, Venkatesh B. Diarrhoea risk factors in enterally tube fed critically ill patients: A retrospective audit. Intensive Crit Care Nurs 2010;26(6):327\u2013334. DOI: 10.1016\/j.iccn.2010.08.001.","DOI":"10.1016\/j.iccn.2010.08.001"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Jack L, Coyer F, Courtney M, Venkatesh B. Probiotics and diarrhoea management in enterally tube-fed critically ill patients: What is the evidence? Intensive Crit Care Nurs 2010;26(6):314\u2013326. DOI: 10.1016\/j.iccn.2010.07.001.","DOI":"10.1016\/j.iccn.2010.07.001"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013;108(5):718\u2013727. DOI: 10.1038\/ajg.2013.63.","DOI":"10.1038\/ajg.2013.63"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Spapen H, Diltoer M, Van Malderen C, Opdenacker G, Suys E, Huyghens L. Soluble fibre reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: A prospective, double-blind, randomised controlled trial. Clin Nutr 2001;20(4):301\u2013305. DOI: 10.1054\/clnu.2001.0399.","DOI":"10.1054\/clnu.2001.0399"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Schultz AA, Ashby-Hughes B, Taylor R, Gillis DE, Wilkins M. Effects of pectin on diarrhoea in critically ill tube-fed patients receiving antibiotics. Am J Crit Care 2000;9(6):403\u2013411. PMID: 11072556.","DOI":"10.4037\/ajcc2000.9.6.403"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Whelan K, Judd PA, Preedy VR, Taylor MA. Enteral feeding: The effect on faecal output, the faecal microflora and SCFA concentrations. Proc Nutr Soc 2004;63(1):105\u2013113. DOI: 10.1079\/pns2003317.","DOI":"10.1079\/PNS2003317"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Iapichino G, Callegari ML, Marzorati S, Cigada M, Corbella D, Ferrari S, et al. Impact of antibiotics on gut microbiota of critically ill patients. J Med Microbiol 2008;57:1007\u20131014. DOI: 10.1099\/jmm.0.47387-0.","DOI":"10.1099\/jmm.0.47387-0"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Amante PR, Santos ECZ, Correia VTV, Fante CA. Benefits and possible food applications of arrowroot (iMaranta arundinaceae L.\/i). J Culin Sci Technol 2020;19(306):1\u20139. DOI: 10.1080\/15428052.2020.1791295.","DOI":"10.1080\/15428052.2020.1791295"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Fidianingsih I, Aryandono T, Widyarini S, Herwiyanti S. Arrowroot (iMaranta arundinacea L.\/i) as a new potential functional food: A scoping review. Int Food Res J 2022;29(6):1240\u20131255. DOI: 10.47836\/ifrj.29.6.02.","DOI":"10.47836\/ifrj.29.6.02"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Kusbandari A, Susanti H. Determination of total phenolic content and antioxidant activity of methanol extract of iMaranta arundinacea L\/i fresh leaf and tuber. IOP Conf Ser Mater Sci Eng 2017;259:012010. DOI: 10.1088\/1757-899X\/259\/1\/012010.","DOI":"10.1088\/1757-899X\/259\/1\/012010"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016;40(2):159\u2013211. DOI: 10.1177\/0148607115621863.","DOI":"10.1177\/0148607115621863"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Venegas-Borsellino C, Kwon M. Impact of soluble fibre in the microbiome and outcomes in critically ill patients. Curr Nutr Rep 2019;8(4):347\u2013355. DOI: 10.1007\/s13668-019-00299-9.","DOI":"10.1007\/s13668-019-00299-9"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Manzanares W, Langlois PL, Wischmeyer PE. Restoring the microbiome in critically ill patients: Are probiotics our true friends when we are seriously ill? JPEN J Parenter Enteral Nutr 2017;41(4):530\u2013533. DOI: 10.1177\/0148607117700572.","DOI":"10.1177\/0148607117700572"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Naseri A, Seyedi-Sahebari S, Mahmoodpoor A, Sanaie S. Probiotics in critically ill patients: An umbrella review. Indian J Crit Care Med 2022;26(3):339\u2013360. DOI: 10.5005\/jp-journals-10071-24129.","DOI":"10.5005\/jp-journals-10071-24129"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Jayampathi T, Jayatilake S. Arrowroot (iMaranta arundinacea\/i) extract increases survival of iLactobacillus acidophilus\/i. J Probiotics Health 2018;6:1\u20135. DOI: 10.4172\/2329-8901.1000199.","DOI":"10.4172\/2329-8901.1000199"},{"key":"ref=18","unstructured":"18. Harmayani E, Kumalasari DI, Marsono Y. Effect of arrowroot (iMaranta arundinacea L\/i.) diet on the selected bacterial population and chemical properties of caecal digesta of Sprague Dawley rats. Int Res J Microbiol 2011;2(8):278\u2013284. Available from: http:\/\/www.interesjournals.org\/IRJM."},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Cooke C, Carr I, Abrams K, Mayberry J. Arrowroot as a treatment for diarrhoea in irritable bowel syndrome patients: A pilot study. Arq Gastroenterol 2000;37(1):20\u201324. DOI: 10.1590\/S0004-28032000000100005.","DOI":"10.1590\/S0004-28032000000100005"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"20. Kim SY, Yim HJ, Ahn J, Kim JH, Kim JN, Yoon I, et al. Two cases of toxic hepatitis caused by arrowroot juice. Korean J Hepatol 2009;15(4):504\u2013509. DOI: 10.3350\/kjhep.2009.15.4.504.","DOI":"10.3350\/kjhep.2009.15.4.504"},{"key":"ref=21","unstructured":"21. Tarleton SM, Kraft CA, Dibaise JK, Rising P. Fiber-enriched enteral formulae: Advantageous or adding fuel to the fire? Pract Gastroenterol 2013;37(12):22\u201331."},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"22. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA. What is Subjective Global Assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987;11(1):8\u201313. DOI: 10.1177\/014860718701100108.","DOI":"10.1177\/014860718701100108"},{"key":"ref=23","unstructured":"23. United States Department of Agriculture. National Nutrient Database for Standard Reference: Arrowroot Flour. USDA; 2018."},{"key":"ref=24","unstructured":"24. World Health Organization. Diarrhoea Definition. WHO; 2016. Available from: http:\/\/www.who.int\/topics\/diarrhoea\/en\/."},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"25. Dionne JC, Sullivan K, Mbuagbaw L, Takaoka A, Duan EH, Alhazzani W, et al. Diarrhoea: Interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): A protocol for a prospective multicentre cohort study. BMJ Open 2019;9:e028237. DOI: 10.1136\/bmjopen-2018-028237.","DOI":"10.1136\/bmjopen-2018-028237"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"26. Murali M, Ly C, Tirlapur N, Montgomery HE, Cooper JA, Wilson AP. Diarrhoea in critical care is rarely infective, associated with increased length of stay and higher mortality. J Intensive Care Soc 2020;21(1):72\u201378. DOI: 10.1177\/1751143719843423.","DOI":"10.1177\/1751143719843423"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"27. Seifi N, Jafarzadeh Esfahani A, Sedaghat A, Rezvani R, Khadem-Rezaiyan M, Nematy M, et al. Effect of gut microbiota modulation on feeding tolerance of enterally fed critically ill adult patients: A systematic review. Syst Rev 2021;10(1):95. DOI: 10.1186\/s13643-021-01633-5.","DOI":"10.1186\/s13643-021-01633-5"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"28. Tuncay P, Arpaci F, Doganay M, Erdem D, Sahna A, Ergun H, et al. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: A randomized controlled study among neuro-critical care patients. Clin Nutr ESPEN 2018;25:26\u201336. DOI: 10.1016\/j.clnesp.2018.03.123.","DOI":"10.1016\/j.clnesp.2018.03.123"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"29. Shimizu K, Yamada T, Ogura H, Mohri T, Kiguchi T, Fujimi S, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: A randomized controlled trial. Crit Care 2018;22(1):239. DOI: 10.1186\/s13054-018-2167-x.","DOI":"10.1186\/s13054-018-2167-x"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"30. Knight DJW, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S. Effect of synbiotic therapy on the incidence of ventilator-associated pneumonia in critically ill patients: A randomized, double-blind, placebo-controlled trial. Intensive Care Med 2009;35(5):854\u2013861. DOI: 10.1007\/s00134-008-1368-1.","DOI":"10.1007\/s00134-008-1368-1"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"31. Li C, Liu L, Gao Z, Zhang J, Chen H, Ma S, et al. Synbiotic therapy prevents nosocomial infection in critically ill adults: A systematic review and network meta-analysis of randomized controlled trials based on a Bayesian framework. Front Med (Lausanne) 2021;8:693188. DOI: 10.3389\/fmed.2021.693188.","DOI":"10.3389\/fmed.2021.693188"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.5005\/jp-journals-10071-25166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:20:38Z","timestamp":1776759638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.5005\/jp-journals-10071-25166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"alternative-id":["10.5005\/jp-journals-10071-25166"],"URL":"https:\/\/doi.org\/10.5005\/jp-journals-10071-25166","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}